Bệnh thiếu máu huyết tán Beta (ở trẻ em)
Bệnh thiếu máu huyết tán Beta thể trung gian và thể nhẹ—Thuốc sản sinh hemoglobin thai nhi
Liệu pháp Hydroxyurea (Hydroxycarbamide)
Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (opens new window)
Nguồn: J Pediatr Hematol Oncol 2011;33(5):339-43.
Mã bài: PubMed 21602718
DOI: 10.1097/MPH.0b013e31821b0770
https://www.ncbi.nlm.nih.gov/pubmed/21602718 (opens new window)
Gγ-Xmn I polymorphism: a significant determinant of β-thalassemia treatment without blood transfusion. (opens new window)
Nguồn: J Pediatr Hematol Oncol 2013;35(4):e153-6.
Mã bài: PubMed 23389500
DOI: 10.1097/MPH.0b013e31827e8662
https://www.ncbi.nlm.nih.gov/pubmed/23389500 (opens new window)
Efficacy of hydroxyurea (HU) in reduction of pack red cell (PRC) transfusion requirement among children having beta-thalassemia major: Karachi HU trial (KHUT). (opens new window)
Nguồn: J Pediatr Hematol Oncol 2007;29(11):743-6.
Mã bài: PubMed 17984691
DOI: 10.1097/MPH.0b013e318157fd75
https://www.ncbi.nlm.nih.gov/pubmed/17984691 (opens new window)
Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia. (opens new window)
Nguồn: Blood 2003;102(4):1529-30.
Mã bài: PubMed 12702505
DOI: 10.1182/blood-2003-01-0117
https://www.ncbi.nlm.nih.gov/pubmed/12702505 (opens new window)
Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (opens new window)
Nguồn: Transfusion 2007;47(10):1830-6.
Mã bài: PubMed 17880608
DOI: 10.1111/j.1537-2995.2007.01399.x
https://www.ncbi.nlm.nih.gov/pubmed/17880608 (opens new window)
Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (opens new window)
Nguồn: Iran J Blood Cancer 2009;1(4):147-50.
Mã bài: IMEMR 107228
https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (opens new window)
Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (opens new window)
Nguồn: Int J Hematol 2012;95(1):51-6.
Mã bài: PubMed 22180324
DOI: 10.1007/s12185-011-0985-6
https://www.ncbi.nlm.nih.gov/pubmed/22180324 (opens new window)
Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (opens new window)
Nguồn: Pediatr Ann 2008;37(5):339-46.
Mã bài: PubMed 18543545
https://www.ncbi.nlm.nih.gov/pubmed/18543545 (opens new window)
Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (opens new window)
Nguồn: Haematologica 2004;89(10):1172-8.
Mã bài: PubMed 15477200
https://www.ncbi.nlm.nih.gov/pubmed/15477200 (opens new window)
Hydroxyurea therapy in 49 patients with major beta-thalassemia. (opens new window)
Nguồn: Arch Iran Med 2009;12(3):295-7.
Mã bài: PubMed 19400608
https://www.ncbi.nlm.nih.gov/pubmed/19400608 (opens new window)
Erythropoietin tái tổ hợp (dùng riêng hoặc kết hợp với các thuốc khác)
Use of hydroxyurea and recombinant erythropoietin in management of homozygous ß⁰ thalassemia. (opens new window)
Nguồn: J Pediatr Hematol Oncol 2002;24(9):777-8.
Mã bài: PubMed 12468925
https://www.ncbi.nlm.nih.gov/pubmed/12468925 (opens new window)
Termination of transfusion dependence in beta-thalassemia: two-year experience with recombinant human erythropoietin. (opens new window)
Nguồn: Pediatr Hematol Oncol 1997;14(3):285-7.
Mã bài: PubMed 9185215
https://www.ncbi.nlm.nih.gov/pubmed/9185215 (opens new window)
Các thuốc khác
Fetal globin gene inducers: novel agents and new potential. (opens new window)
Nguồn: Ann N Y Acad Sci 2010;1202:158-64.
Mã bài: PubMed 20712788
DOI: 10.1111/j.1749-6632.2010.05593.x
https://www.ncbi.nlm.nih.gov/pubmed/20712788 (opens new window)